Cierra N. Sharp

Cierra N. Sharp

Aug 15, 2016

Group 6 Copy 25
-1
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Help me sequence wild populations of a medicinal plant (Pilocarpus)

    I'm studying an important medicinal plant in the citrus family, commonly known as Jaborandi(Pilocarpus). Compounds...

    Monitoring the movement of invasive lionfish

    We hypothesize that invasive lionfish settle in typical nursery habitats before searching out deeper, colder...

    Backer Badge Funded